Trial · NCT00511199
Results by group218
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 218
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of In-treatment Pregnancies (With +2 Day Window) Per 100 Woman Years of Exposure (Pearl Index) | NOMAC-E2 | Overall group | 0.467 | 95% Confidence Interval 0.1271 to 1.1948 | Pregnancies per 100 woman years |
| Number of In-treatment Pregnancies (With +2 Day Window) Per 100 Woman Years of Exposure (Pearl Index) | DRSP-EE | Overall group | 1.017 | 95% Confidence Interval 0.2097 to 2.971 | Pregnancies per 100 woman years |
| Number of In-treatment Pregnancies (With +2 Day Window) Per 100 Woman Years of Exposure (Pearl Index) | NOMAC-E2 | =<35 years old (n= 1193; n=402) | 0.571 | 95% Confidence Interval 0.1555 to 1.4614 | Pregnancies per 100 woman years |
| Number of In-treatment Pregnancies (With +2 Day Window) Per 100 Woman Years of Exposure (Pearl Index) | DRSP-EE | =<35 years old (n= 1193; n=402) | 1.261 | 95% Confidence Interval 0.2601 to 3.6858 | Pregnancies per 100 woman years |
| Number of In-treatment Pregnancies (With +2 Day Window) Per 100 Woman Years of Exposure (Pearl Index) | NOMAC-E2 | >35 years old (n= 249; n=84) | 0.000 | 95% Confidence Interval 0 to 2.3594 | Pregnancies per 100 woman years |
| Number of In-treatment Pregnancies (With +2 Day Window) Per 100 Woman Years of Exposure (Pearl Index) | DRSP-EE | >35 years old (n= 249; n=84) | 0.000 | 95% Confidence Interval 0 to 6.4466 | Pregnancies per 100 woman years |
| Number of In-treatment Pregnancies (With +14 Day Window) Per 100 Woman Years of Exposure (Pearl Index) | NOMAC-E2 | Overall group | 0.817 | 95% Confidence Interval 0.3283 to 1.6826 | Pregnancies per 100 woman years |
| Number of In-treatment Pregnancies (With +14 Day Window) Per 100 Woman Years of Exposure (Pearl Index) | DRSP-EE | Overall group | 1.356 | 95% Confidence Interval 0.3693 to 3.4707 | Pregnancies per 100 woman years |
| Number of In-treatment Pregnancies (With +14 Day Window) Per 100 Woman Years of Exposure (Pearl Index) | NOMAC-E2 | =<35 years old (n=1193; n=402) | 0.999 | 95% Confidence Interval 0.4016 to 2.058 | Pregnancies per 100 woman years |
| Number of In-treatment Pregnancies (With +14 Day Window) Per 100 Woman Years of Exposure (Pearl Index) | DRSP-EE | =<35 years old (n=1193; n=402) | 1.682 | 95% Confidence Interval 0.4582 to 4.3056 | Pregnancies per 100 woman years |
| Number of In-treatment Pregnancies (With +14 Day Window) Per 100 Woman Years of Exposure (Pearl Index) | NOMAC-E2 | >35 years old (n=249; n=84) | 0.000 | 95% Confidence Interval 0 to 2.3594 | Pregnancies per 100 woman years |
| Number of In-treatment Pregnancies (With +14 Day Window) Per 100 Woman Years of Exposure (Pearl Index) | DRSP-EE | >35 years old (n=249; n=84) | 0.000 | 95% Confidence Interval 0 to 6.4466 | Pregnancies per 100 woman years |
| Number of Participants With an Occurrence of Breakthrough Bleeding/Spotting | NOMAC-E2 | Cycle 1 (n=1466 NOMAC-E2; n=470 DRSP-EE) | 483 | participants | |
| Number of Participants With an Occurrence of Breakthrough Bleeding/Spotting | DRSP-EE | Cycle 1 (n=1466 NOMAC-E2; n=470 DRSP-EE) | 130 | participants | |
| Number of Participants With an Occurrence of Breakthrough Bleeding/Spotting | NOMAC-E2 | Cycle 2 (n=1339 NOMAC-E2; n=440 DRSP-EE) | 289 | participants | |
| Number of Participants With an Occurrence of Breakthrough Bleeding/Spotting | DRSP-EE | Cycle 2 (n=1339 NOMAC-E2; n=440 DRSP-EE) | 75 | participants | |
| Number of Participants With an Occurrence of Breakthrough Bleeding/Spotting | NOMAC-E2 | Cycle 3 (n=1233 NOMAC-E2; n=398 DRSP-EE) | 297 | participants | |
| Number of Participants With an Occurrence of Breakthrough Bleeding/Spotting | DRSP-EE | Cycle 3 (n=1233 NOMAC-E2; n=398 DRSP-EE) | 54 | participants | |
| Number of Participants With an Occurrence of Breakthrough Bleeding/Spotting | NOMAC-E2 | Cycle 4 (n=1135 NOMAC-E2; n=389 DRSP-EE) | 231 | participants | |
| Number of Participants With an Occurrence of Breakthrough Bleeding/Spotting | DRSP-EE | Cycle 4 (n=1135 NOMAC-E2; n=389 DRSP-EE) | 59 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00511199/results